2022
DOI: 10.1001/jama.2022.15227
|View full text |Cite
|
Sign up to set email alerts
|

The Critical Need to Modernize Syphilis Screening

Abstract: 5. Zuckerman B. PMA supplement approval letter for the HeartMate 3 LVAS. US Food and Drug Administration. October 18, 2018. Accessed August 27, 2022. https://www.accessdata.fda.gov/cdrh_ docs/pdf16/p160054s008a.pdf 6. Mehra MR, Goldstein DJ, Cleveland JC Jr, et al. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial. JAMA.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 17 publications
(18 reference statements)
0
2
0
Order By: Relevance
“…The extent of sexually risky behaviour over time is the strongest risk factor for repeated syphilis episodes when compared to other indicators (antiretroviral regimen or immunological status) [26]. The identification of at-risk adults and adolescents is crucial to improve syphilis screening strategies, as recommended by the latest USPSTF (US Preventive Services Task Force) statements [27][28][29]. While the interpretation of the indirect methods for syphilis diagnosis is relatively straightforward in patients without a prior history of syphilis, it becomes more complex in the case of reinfections, as treponemal antibodies mostly remain positive for their entire life cycle, tests lack sensitivity in early infection (as well as when patients are contagious), and non-treponemal titres often lead to difficult-to-interpret serological responses after treatment [29].…”
Section: Discussionmentioning
confidence: 99%
“…The extent of sexually risky behaviour over time is the strongest risk factor for repeated syphilis episodes when compared to other indicators (antiretroviral regimen or immunological status) [26]. The identification of at-risk adults and adolescents is crucial to improve syphilis screening strategies, as recommended by the latest USPSTF (US Preventive Services Task Force) statements [27][28][29]. While the interpretation of the indirect methods for syphilis diagnosis is relatively straightforward in patients without a prior history of syphilis, it becomes more complex in the case of reinfections, as treponemal antibodies mostly remain positive for their entire life cycle, tests lack sensitivity in early infection (as well as when patients are contagious), and non-treponemal titres often lead to difficult-to-interpret serological responses after treatment [29].…”
Section: Discussionmentioning
confidence: 99%
“…There were 24 cases of syphilis in pregnant women at the WRSU in 2022, representing 15.9% of all female syphilis cases and 6% of all patients with a positive pregnancy test over the same period. Although syphilis in pregnancy and among women of childbearing age has increased nationally, 1,22 it is difficult to find data comparing percentage of women with positive pregnancy tests and new syphilis cases nationally or in other jurisdictions. The rates of syphilis in pregnancy at the WRSU are similar to what was reported during an outbreak from 2013 to 2015 in an Arizona reservation 14 …”
Section: Discussionmentioning
confidence: 99%